• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型多核壳聚糖微球的制备及亲水性抗生素胃部特异性给药的特性研究。

Preparation and characterization of novel multi-core chitosan microspheres for stomach-specific delivery of hydrophilic antibiotics.

机构信息

Key Laboratory of Drug Targeting and Drug Delivery, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, People's Republic of China.

出版信息

J Mater Sci Mater Med. 2012 Apr;23(4):983-90. doi: 10.1007/s10856-012-4567-9. Epub 2012 Feb 10.

DOI:10.1007/s10856-012-4567-9
PMID:22322786
Abstract

Insufficient gastric mucosa drug concentration and short contact time were the main reason for the lack of eradication efficacy of Helicobacter pylori for peptic ulcer patients. Novel multi-core chitosan microspheres were prepared for stomach-specific delivery of hydrophilic antibiotics for the treatment of peptic ulcer. Chitosan microspheres with multiple Eudragit L100 cores were easily prepared by a new emulsification/coagulation encapsulating method. Swelling behaviors, surface amino groups and mucin absorption ability were investigated and the formulation that showed best mucoadhesive potential was adopted. The multi-core chitosan microspheres exhibited good mucoadhesiveness as well as controlled release manner for incorporated antibiotics in acidic environment. The release rate could be easily modulated with accumulative release ranging from 47.3 to 79.3% in 6 h. Accordingly, the multi-core chitosan microspheres could serve as a satisfactory vehicle for stomach-specific delivery of hydrophilic antibiotics.

摘要

胃酸黏膜药物浓度不足和接触时间短是消化性溃疡患者幽门螺杆菌根除疗效差的主要原因。为了治疗消化性溃疡,将新型多芯壳聚糖微球用于亲水性抗生素的胃内靶向传递。通过一种新的乳化/凝聚包埋方法,很容易制备出具有多个 Eudragit L100 核的壳聚糖微球。考察了溶胀行为、表面氨基和粘蛋白吸收能力,并采用表现出最佳粘膜粘附潜力的配方。多芯壳聚糖微球在酸性环境中对包封的抗生素表现出良好的粘膜粘附性和控制释放方式。通过 6 小时内的累积释放,释放率可轻松调节,在 47.3%至 79.3%的范围内。因此,多芯壳聚糖微球可以作为一种理想的亲水性抗生素胃内靶向传递载体。

相似文献

1
Preparation and characterization of novel multi-core chitosan microspheres for stomach-specific delivery of hydrophilic antibiotics.新型多核壳聚糖微球的制备及亲水性抗生素胃部特异性给药的特性研究。
J Mater Sci Mater Med. 2012 Apr;23(4):983-90. doi: 10.1007/s10856-012-4567-9. Epub 2012 Feb 10.
2
Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus.用于根除幽门螺杆菌感染和与黏液相互作用的凝集素偶联微球。
Int J Pharm. 2014 Aug 15;470(1-2):28-40. doi: 10.1016/j.ijpharm.2014.04.070. Epub 2014 May 2.
3
Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.胃部特异性抗幽门螺杆菌疗法:载阿莫西林壳聚糖黏膜黏附微球的制备与评价
Curr Drug Deliv. 2007 Jan;4(1):41-50. doi: 10.2174/156720107779314811.
4
Mucoadhesive and floating chitosan-coated alginate beads for the controlled gastric release of amoxicillin.壳聚糖-海藻酸钠黏附性和漂浮性微球用于控制阿莫西林的胃内释放。
Arch Pharm Res. 2010 Jun;33(6):889-99. doi: 10.1007/s12272-010-0612-8. Epub 2010 Jul 6.
5
Modulation of stability and mucoadhesive properties of chitosan microspheres for therapeutic gastric application.用于治疗胃部疾病的壳聚糖微球的稳定性和粘膜黏附性能的调节。
Int J Pharm. 2013 Sep 15;454(1):116-24. doi: 10.1016/j.ijpharm.2013.06.068. Epub 2013 Jul 11.
6
Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.用于根除幽门螺杆菌的基于美丽决明子的三水合阿莫西林漂浮型生物黏附胃滞留微丸。
Drug Deliv. 2016;23(2):405-19. doi: 10.3109/10717544.2014.916766. Epub 2014 May 28.
7
Chitosan-based mucoadhesive microspheres of clarithromycin as a delivery system for antibiotic to stomach.基于壳聚糖的克拉霉素黏膜黏附微球作为抗生素向胃部的递送系统。
Curr Drug Deliv. 2005 Jul;2(3):235-42. doi: 10.2174/1567201054367995.
8
The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.壳聚糖微/纳米颗粒在治疗胃部感染中的潜在效用。
Expert Rev Anti Infect Ther. 2014 Aug;12(8):981-92. doi: 10.1586/14787210.2014.930663. Epub 2014 Jun 30.
9
Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres.
Int J Pharm. 2002 Mar 20;235(1-2):87-94. doi: 10.1016/s0378-5173(01)00985-1.
10
Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori.带正电荷的明胶微球作为用于根除幽门螺杆菌的胃黏膜黏附给药系统。
Drug Deliv. 2000 Oct-Dec;7(4):237-43. doi: 10.1080/107175400455173.

本文引用的文献

1
Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation.阿那曲唑载壳聚糖微球的缓释优化配方:体外与体内评价。
J Mater Sci Mater Med. 2011 Apr;22(4):865-78. doi: 10.1007/s10856-011-4274-y. Epub 2011 Mar 23.
2
Processing and characterization of chitosan microspheres to be used as templates for layer-by-layer assembly.壳聚糖微球的处理和特性,以作为层层组装的模板。
J Mater Sci Mater Med. 2010 Jun;21(6):1855-65. doi: 10.1007/s10856-010-4055-z. Epub 2010 Apr 3.
3
Chitosan-based hydrogels for controlled, localized drug delivery.
壳聚糖基水凝胶用于控制和局部药物传递。
Adv Drug Deliv Rev. 2010 Jan 31;62(1):83-99. doi: 10.1016/j.addr.2009.07.019. Epub 2009 Sep 30.
4
Preparation of ionic-crosslinked chitosan-based gel beads and effect of reaction conditions on drug release behaviors.离子交联壳聚糖基凝胶珠的制备及反应条件对药物释放行为的影响。
Int J Pharm. 2008 Feb 12;349(1-2):180-7. doi: 10.1016/j.ijpharm.2007.08.029. Epub 2007 Aug 25.
5
Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.用于氨苄西林控释的离子型交联壳聚糖微球。
Int J Pharm. 2006 Apr 7;312(1-2):166-73. doi: 10.1016/j.ijpharm.2006.01.043. Epub 2006 Feb 23.
6
The basics and underlying mechanisms of mucoadhesion.粘膜粘附的基本原理及潜在机制。
Adv Drug Deliv Rev. 2005 Nov 3;57(11):1556-68. doi: 10.1016/j.addr.2005.07.001. Epub 2005 Sep 29.
7
pH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: swelling kinetics and drug delivery properties.由壳聚糖/三聚磷酸钠/硫酸葡聚糖组成的pH敏感聚电解质复合凝胶微球:溶胀动力学和药物递送特性
Colloids Surf B Biointerfaces. 2005 Aug;44(2-3):143-51. doi: 10.1016/j.colsurfb.2005.06.010.
8
Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods.不同方法制备的壳聚糖微球的黏膜黏附性能评价
AAPS PharmSciTech. 2004 Jul 26;5(4):e67. doi: 10.1208/pt050467.
9
Chitosan microspheres as a potential carrier for drugs.壳聚糖微球作为一种潜在的药物载体。
Int J Pharm. 2004 Apr 15;274(1-2):1-33. doi: 10.1016/j.ijpharm.2003.12.026.
10
Stomach-specific anti-H. pylori therapy; part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils.胃特异性抗幽门螺杆菌治疗;第三部分:壳聚糖微球交联对禁食沙鼠胃内滞留及局部四环素浓度的影响。
Int J Pharm. 2004 Mar 19;272(1-2):99-108. doi: 10.1016/j.ijpharm.2003.12.001.